Responsibility for clinical innovation: A case study in neonatal medicine

Evaluation and the Health Professions

Volumn 21, Issue 1, 1998, Pages 3-26

  Miké, Valerie ^a   Krauss, Alfred N ^a   Ross, Gail S ^a  

^a Medical College ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; DIFFUSION; ETHICS; HEALTH CARE POLICY; MEDICAL RESEARCH; NEWBORN INTENSIVE CARE; PULSE OXIMETRY; REPRODUCIBILITY; TECHNICAL AID; TECHNOLOGY; TRANSCUTANEOUS OXYGEN MONITORING;

ATTITUDE OF HEALTH PERSONNEL; BLOOD GAS MONITORING, TRANSCUTANEOUS; DIFFUSION OF INNOVATION; ETHICS, MEDICAL; HEALTH POLICY; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; PHYSICIAN'S ROLE;

EID: 0031917369     PISSN: 01632787     EISSN: None     Source Type: Journal    
DOI: 10.1177/016327879802100101     Document Type: Article

References (21)

1. Altman, L. K. (1976, June 13). Oxygen monitor may reduce birth defects. The New York Times, pp. 1, 50.
2. American Academy of Pediatrics, Task Force on Transcutaneous Oxygen Monitors. (1989). Report of consensus meeting, December 5-6, 1986. Pediatrics, 83, 122-126.
3. Apfel, R. J., & Fisher, S. M. (1984). To do no harm: DES and the dilemmas of modern medicine. New Haven, CT: Yale University Press.
4. Bancalari, E., Flynn, J., Goldberg, R. N., Bawd, R., Cassady, J, Schiffman, J., Feuer, W., Roberts, J., Gillings, D., & Sim, E. (1987). Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics, 79, 663-669.
5. Miké, V., Krauss, A. N., & Ross, G. S. (1996). Doctors and the health industry: Acase study of transcutaneous oxygen monitoring in neonatal intensive care. Social Science & Medicine, 42, 1247-1258.
6. Nelkin, D. (1987). Selling science: How the press covers science and technology. New York: Freeman.
7. Pellegrino, E. D. (1993). The metamorphosis of medical ethics: A 30-year retrospective. Journal of the American Medical Association, 269, 1156-1162.
8. Phelps, D. L. (1992). Retinopathy of prematurity. New England Journal of Medicine, 326, 1078-1080.
9. Product Development Directory. (1988). An historical index to PDA 510(k) filings byproduct category. Greenwich, CT: Directory Systems, Inc.
10. Reiser, S. J. (1978). Medicine and the reign of technology. New York: Cambridge University Press.
11. Rodriguez, L. R., Kotin, N., Lowenthal, D., & Kattan, M. (1994). A study of pediatric house staff's knowledge of pulse oximetry. Pediatrics, 93, 810-813.
12. Rooth, G., Huch, A., & Much, R. (1987). Transcutaneous monitors are reliable indicators of arterial oxygen tension (if used correctly). Pediatrics, 79, 283-286.
13. Severinghaus, J. W., & Astrup, P. (1987). History of blood gas monitoring (International Anesthesiology Clinics, Vol. 25, No. 4). Boston: Little, Brown.
14. Seward, P. J. (1997). Perspective: Restoring the ethical balance in health care. Health Affairs, 16, 195-197.
15. Sharpe, V. A., & Faden, A. I. (1996). Appropriateness in patient care: A new conceptual framework. Milbank Quarterly, 74, 115-138.
16. 2 measurements. Critical Care Medicine, 9, 689-690.
17. Silverman, W. A. (1980). Retrolental fibroplasia: A modern parable. New York: Grune & Stratton.
18. Silverman, W. A. (1986). Epoché in retinopathy of prematurity. Archives of Disease in Childhood, 61, 522-525.
19. Tarlov, A. R. (1987). Microsocial influences on the use of medical innovations. In M. Siegler, S. Toulmin, F. E. Zimring, & K. F. Schaffner (Eds.), Medical innovation and bad outcomes: Legal, social, and ethical responses (pp. 63-67). Ann Arbor, MI: Health Administration Press.
20. The Wilkerson Group; formerly Charming, Weinberg & Co., Inc. (1982, November). Opportunities in transcutaneous, blood gas, and electrolyte monitoring. New York: Author.
21. The Wilkerson Group; formerly Channing, Weinberg & Co., Inc. (1987, January). Biochemical monitoring: A strategic business assessment. New York: Author.